Vendor, Wilmington, NC, part of Pharmaceutical Product Development, LLC
PPD Development LP
UEI ZANENSW6C665, CAGE 3FAW2
44 awards and $65,307,629 obligated between January 5, 2024 and October 26, 2026, 84% under full and open competition, against 29.8 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $79,785,071 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $23,168,748 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | $1,299,218 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | $828,872 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$8,155 |
| Other Scientific and Technical Consulting ServicesNAICS 541690 | -$428,033 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | -$39,338,092 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 37 |
| Competed Under SAP | 5 |
| Not Competed Under SAP | 1 |
| Not Competed | 1 |
| Delivery Order | 21 |
| Definitive Contract | 14 |
| Purchase Order | 2 |
Hear when PPD Development LP wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts PPD Development LP holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 4
- Obligated so far
- $26,006,896
- Soonest
- April 28, 2027
The 4 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
| Coriell Institute for Medical Research, Inc.Camden, NJ | $27,478,642 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
National Institutes of Health, National Institutes of Health Niaid
Award noticeNAICS 541715Wilmington, NC75N98026D00092Awarded to PPD Development LP for $48,000,000
Posted Oct 7 - Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation
Office of Assistant Secretary for Preparedness and Response, Aspr Barda Div Contracts MGMT & Acq
JustificationNAICS 541715Wilmington, NCBARDA-IEIDD-063025Awarded to PPD Development LP
Posted Jun 30, 2025
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024F00001Delivery Order, January 24, 2024, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Niaid Clinical Site Monitoring (Ncsm)NAICS 541714, PSC AN12 | $73,196,564 |
| 75N93024F00002Delivery Order, August 7, 2024, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Comprehensive and Rapid Response for Niaid Research Programs Hiv and Other Infectious Diseases Clinical Research Support Services (Crss)NAICS 541714, PSC AN42 | $26,101,778 |
| 75N93022C00014Definitive Contract, May 23, 2024, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | National Institute of Allergy and Infectious Diseases (Niaid) Clinical Site Monitoring Center (Csmc)NAICS 541715, PSC AN12 | $21,966,386 |
| 75N93022C00001Definitive Contract, May 29, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Regulatory Management Center (Rmc)NAICS 541714, PSC AN12 | $9,090,357 |
| 75N93026F00001Delivery Order, December 10, 2025, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Daids Monitoring for 1 Phase III Study: A5300b/I2003b (Phoenix)NAICS 541714, PSC AN42 | $3,092,829 |
| 75N95024F00001Delivery Order, July 1, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | First in Human Randomized, Double-Blind, Placebo Controlled Single Ascending Dose (Sad) Phase I StudyNAICS 541712, PSC AN12 | $2,773,098 |
| 75N98026F00001Delivery Order, June 26, 2026, Full and Open Competition, 2 offers | National Institutes of Health OlaoNational Institutes of Health | Task Order Award- Phase I Clinical Trials for the Development of Neurotherapeutics- DTI-117 in Healthy Volunteers/Sad and Mad CTNAICS 541712, PSC AN12 | $2,016,831 |
| 75N93019F00131Delivery Order, April 12, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | Daids Onsite Monitoring for 1 Phase III Study: A5300b/PhoenixNAICS 541711, PSC AN12 | $1,301,001 |
| 75F40124C00134Definitive Contract, September 24, 2024, Not Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Baa-Fy24c3cp5-Understanding Heterogeneity in Preferences for Clinical Trial Participation in Diverse Patient Populations.NAICS 541720, PSC AJ11 | $1,299,218 |
| 75F40124C00117Definitive Contract, September 11, 2024, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Fdabaa-24-00123, Ref # Fy24c1ep6, Cardiovascular-Kidney-Metabolic (Ckm) Syndrome Patient-Reported Outcome (Pro) Burden MeasureNAICS 541714, PSC B529 | $724,461 |
| 75N93022F00001Delivery Order, January 5, 2024, Full and Open Competition, 6 offers | National Institutes of Health NiaidNational Institutes of Health | Task Area A: Administration and Overall Clinical Operations Support and Concept DevelopmentNAICS 541715, PSC AN12 | $549,285 |
| 75N95022C00036Definitive Contract, September 17, 2024, Competed Under SAP, 5 offers | National Institutes of Health NidaNational Institutes of Health | Clinical Research and Study Monitoring Support for Nimh StudiesNAICS 541990, PSC R499 | $437,516 |
| 75N95024F00001Delivery Order, April 9, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Consulting Assistance for Medical Device Developer. Research and Development for Clinical Studies in the Blueprint Medtech. Pre-SNAICS 541715, PSC AN11 | $370,621 |
| 75N95024F00001Delivery Order, June 17, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Research and Development for Clinical Studies in the Blueprint Medtech. Clinical Study Protocol Development. Task Order 02. 06/17/2024 - 06/NAICS 541715, PSC AN11 | $324,420 |
| 75N95024F00002Delivery Order, July 15, 2024, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Phase I Randomized Double-Blind Placebo-Controlled Study to Assess Safety, Tolerability, and PharmacokineticsNAICS 541712, PSC AN12 | $305,772 |
| 75F40123C00198Definitive Contract, April 17, 2024, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Assessing Clinical Site Readiness: a Framework to Support Enrollment of Under-Represented Minorities in Medical Device Clinical Trials (Fy23NAICS 541714, PSC AN11 | $44,810 |
| 75N95023F00001Delivery Order, June 12, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Consulting Assistance for Medical Device Developer. Research and Development for Clinical Studies in the Blueprint Medtech. Task NAICS 541715, PSC AN11 | $31,102 |
| 75N95025F00001Delivery Order, December 20, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Task Order75n95025f00001 TO4 Blueprint Medtech Preparation of Pre-Submission Support for Pilot Participant.NAICS 541715, PSC AN11 | $5,334 |
| 47QRCA25DU259December 17, 2024, Full and Open Competition, 766 offers | Gsa/Fas/Pshc/Oasis PlusFederal Acquisition Service | One Acquisition Solution for Integrated Services Plus (Oasis+) Unrestricted Multiple Agency Contract (Mac)NAICS 541690, PSC R499 | $2,500 |
| 75A50121P00004Purchase Order, June 6, 2024, Competed Under SAP, 2 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Establishment of High Throughput Sars-Cov-2 Binding Antibody Immunoassay Capability and Testing of Human Serum Samples: Modified to Remove RNAICS 541715, PSC AN13 | $0 |
| 75A50123C00045Definitive Contract, February 29, 2024, Not Competed, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advanced Research and Development Activities for Novel Immunogenicity Assays and Sample Collection Technologies as Part of Barda?s ContinuinNAICS 541715, PSC AN12 | $0 |
| 75A50124C00001Definitive Contract, August 30, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Barda Will Implement a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial in the US to Evaluate the Safety and EfficacyNAICS 541714, PSC AN12 | $0 |
| 75N93023F00001Delivery Order, August 28, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | Epctu - to Implement Phase 0 to Phase II Clinical Trials, Including Proof-Of-Concept Studies in Healthy and Diseased Human Populations, DomeNAICS 541715, PSC AN12 | $0 |
| 75N93021D00035March 12, 2026, Full and Open Competition, 29 offers | National Institutes of Health NiaidNational Institutes of Health | Comprehensive and Rapid Response for Niaid Research ProgramsNAICS 541714, PSC AN42 | $0 |
| 75N93022D00017July 5, 2024, Full and Open Competition, 6 offers | National Institutes of Health NiaidNational Institutes of Health | Early Phase Clinical Trial Units (Epctu)NAICS 541715, PSC AN12 | $0 |
| 75N95022D00020December 13, 2024, Full and Open Competition, 6 offers | National Institutes of Health NidaNational Institutes of Health | Contract Research Organization (Cro) Support for Blueprint Medtech (Bpmt) Regulatory Affairs Support and Related Services. Ordering Period: NAICS 541715, PSC AN11 | $0 |
| 75N95023D00011December 13, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Research and Development for Clinical Studies in the Blueprint Medtech. Ordering Period: 09/01/2023 - 8/31/2028. (Bpmt) Initiative.NAICS 541715, PSC AN11 | $0 |
| HHSN271201800007IApril 18, 2024, Full and Open Competition, 4 offers | National Institutes of Health NidaNational Institutes of Health | PPD - Cro Support for Ncats Bioanalytical Method Development for BiologicsNAICS 541715, PSC AN11 | $0 |
| HT001122D0040October 16, 2024, Full and Open Competition, 126 offers | Defense Health AgencyDefense Health Agency | Omnibus IV Military Medical Research and DevelopmentNAICS 541714, PSC AN14 | $0 |
| 0011Delivery Order, April 30, 2024, Full and Open Competition, 2 offers | Army Med Res Acq ActivityDefense Health Agency | Training Services in Support of Ora.NAICS 541712, PSC AJ53 | -$99 |
| 75N93021F00001Delivery Order, September 3, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541714, PSC AN42 | -$2,000 |
| 75N92019C00005Definitive Contract, April 28, 2025, Competed Under SAP, 4 offers | National Institutes of Health NhlbiNational Institutes of Health | Clinical Site and Study Monitoring Support Services for the National Heart, Lung, and Blood Institute'S Hypertension Outcomes for T4 ResearcNAICS 541990, PSC R499 | -$12,975 |
| 75N95018F00002Delivery Order, April 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Petrukhin Phase I Clinical Trial for Development of NeurotherapeuticsNAICS 541712, PSC AN12 | -$33,049 |
| W81XWH18F0195Delivery Order, December 18, 2024, Full and Open Competition, 1 offers | Army Med Res Acq ActivityDefense Health Agency | Hiv Cohort StudyNAICS 541712, PSC AJ53 | -$53,388 |
| 75N95018F00001Delivery Order, March 26, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | PPD Development LP:1106692 [18-007540]. Modification to (1) Change the Period of Performance; (2) Add Optional Tasks to the Statement of WorNAICS 541715, PSC AN11 | -$78,400 |
| HHSN272201200002CDefinitive Contract, May 22, 2024, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | Regulatory Management CenterNAICS 541711, PSC AN11 | -$96,445 |
| 75N95019F00089Delivery Order, April 30, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Buckpitt-Phase I Single Ascending Dose Study-Bpn-19186 (EC5026)NAICS 541712, PSC AN12 | -$272,785 |
| HHSN272201200004CDefinitive Contract, February 11, 2025, Full and Open Competition, 7 offers | National Institutes of Health NiaidNational Institutes of Health | Niaid Dait Clinical Site Monitoring CenterNAICS 541711, PSC AN11 | -$375,684 |
| 75D30121C11269Definitive Contract, March 6, 2024, Full and Open Competition, 5 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | TBTC MonitoringNAICS 541690, PSC R499 | -$430,533 |
| HHSN271201700007APurchase Order, June 24, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Study and Site Monitoring ServicesNAICS 541990, PSC R707 | -$432,696 |
| HHSN272201700004CDefinitive Contract, May 8, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | Niaid Clinical Site MonitoringNAICS 541712, PSC AN81 | -$10,609,694 |
| 75N93022F00001Delivery Order, July 9, 2025, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Support Services for Activ 2NAICS 541714, PSC AN42 | -$13,963,728 |
| 75N93022F00002Delivery Order, October 29, 2024, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | "covid 19" Completion of Activ 2 StudyNAICS 541714, PSC AN42 | -$18,500,000 |
| HHSN272201700078CDefinitive Contract, July 8, 2024, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | To Provide a Broad Range of Clinical and Other Related Research Support Services for Activ2 Clinical Trial. Also Provide a Broad Range of ClNAICS 541712, PSC AN81 | -$33,464,778 |
- Places of performance
- North CarolinaMaryland
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchAJ11 General Science And Technology R&D Services; General Science And Technology; Basic ResearchB529 Scientific Data StudiesAN11 Health R&D Services; Health Care Services; Basic ResearchAN13 Health R&D Services; Health Care Services; Experimental DevelopmentAN14 Health R&D Services; Health Care Services; R&D Administrative Expenses
- Transactions
- 132 across 44 awards